Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1997
Molecular aspects of UVB-induced immunosuppression
J Garssen, R J Vandebriel, H van Loveren
Toxicology
|
December 10, 1998
Altered cytokine (receptor) mRNA expression as a tool in immunotoxicology
R J Vandebriel, H Van Loveren, C Meredith
Community Genetics
|
September 27, 2007
Genetic variation in the response to vaccination
T G Kimman, R J Vandebriel, B Hoebee
Methods in Molecular Biology (Clifton, N.J.)
|
December 8, 2009
In vitro testing for direct immunotoxicity: state of the art
D P K Lankveld, H Van Loveren, K A Baken, et al.
Thymus
|
January 1, 1989
Sequential activity of gamma-delta T-cell receptor bearing lymphocytes, specific T-cell factors, and alpha-beta T-cell receptor bearing T-cells: a hypothesis
R A de Weger, H van Loveren, R J Vandebriel, et al.
Toxicology
|
August 24, 1999
In vitro exposure effects of cyclosporin A and bis(tri-n-butyltin)oxide on lymphocyte proliferation, cytokine (receptor) mRNA expression, and cell surface marker expression in rat thymocytes and splenocytes
R J Vandebriel, S W Spiekstra, B N Hudspith, et al.
Scandinavian Journal of Immunology
|
December 19, 2000
Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not
R J Vandebriel, C Meredith, M P Scott, et al.
Toxicology and Applied Pharmacology
|
February 18, 1998
Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels
R J Vandebriel, C Meredith, M P Scott, et al.
Immunobiology
|
June 1, 1989
Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF)
J W De Groot, R A De Weger, R J Vandebriel, et al.
Toxicology Letters
|
February 18, 1999
Risk assessment and immunotoxicology
H Van Loveren, W H De Jong, R J Vandebriel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1997
Molecular aspects of UVB-induced immunosuppression
J Garssen, R J Vandebriel, H van Loveren
Toxicology
|
December 10, 1998
Altered cytokine (receptor) mRNA expression as a tool in immunotoxicology
R J Vandebriel, H Van Loveren, C Meredith
Community Genetics
|
September 27, 2007
Genetic variation in the response to vaccination
T G Kimman, R J Vandebriel, B Hoebee
Methods in Molecular Biology (Clifton, N.J.)
|
December 8, 2009
In vitro testing for direct immunotoxicity: state of the art
D P K Lankveld, H Van Loveren, K A Baken, et al.
Thymus
|
January 1, 1989
Sequential activity of gamma-delta T-cell receptor bearing lymphocytes, specific T-cell factors, and alpha-beta T-cell receptor bearing T-cells: a hypothesis
R A de Weger, H van Loveren, R J Vandebriel, et al.
Toxicology
|
August 24, 1999
In vitro exposure effects of cyclosporin A and bis(tri-n-butyltin)oxide on lymphocyte proliferation, cytokine (receptor) mRNA expression, and cell surface marker expression in rat thymocytes and splenocytes
R J Vandebriel, S W Spiekstra, B N Hudspith, et al.
Scandinavian Journal of Immunology
|
December 19, 2000
Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not
R J Vandebriel, C Meredith, M P Scott, et al.
Toxicology and Applied Pharmacology
|
February 18, 1998
Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels
R J Vandebriel, C Meredith, M P Scott, et al.
Immunobiology
|
June 1, 1989
Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF)
J W De Groot, R A De Weger, R J Vandebriel, et al.
Toxicology Letters
|
February 18, 1999
Risk assessment and immunotoxicology
H Van Loveren, W H De Jong, R J Vandebriel, et al.
Page
of 3